Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Neuro-Oncological Ventral Antigen 1 (NOVA1) (Middle Region) Peptide

NOVA1 Reactivité: Humain Hôte: Synthetic BP, WB
N° du produit ABIN980818

Aperçu rapide pour Neuro-Oncological Ventral Antigen 1 (NOVA1) (Middle Region) Peptide (ABIN980818)

Antigène

NOVA1 (Neuro-Oncological Ventral Antigen 1 (NOVA1))

Origine

Humain

Source

  • 5
Synthetic

Application

Blocking Peptide (BP), Western Blotting (WB)
  • Protein Region

    Middle Region

    Attributs du produit

    This is a synthetic peptide designed for use in combination with anti-NOVA1 antibody (Catalog #: ARP40398_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.

    Purification

    Purified
  • Indications d'application

    Each Investigator should determine their own optimal working dilution for specific applications.

    Restrictions

    For Research Use only
  • Format

    Lyophilized

    Reconstitution

    Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.

    Concentration

    1 mg/mL

    Buffer

    Final peptide concentration is 1 mg/mL in PBS.

    Conseil sur la manipulation

    Avoid repeated freeze-thaw cycles.

    Stock

    -20 °C

    Stockage commentaire

    For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
  • Antigène

    NOVA1 (Neuro-Oncological Ventral Antigen 1 (NOVA1))

    Sujet

    NOVA1 is a neuron-specific RNA-binding protein, a member of the Nova family of paraneoplastic disease antigens, that is recognized and inhibited by paraneoplastic antibodies. These antibodies are found in the sera of patients with paraneoplastic opsoclonus-ataxia, breast cancer, and small cell lung cancer. This gene encodes a neuron-specific RNA-binding protein, a member of the Nova family of paraneoplastic disease antigens, that is recognized and inhibited by paraneoplastic antibodies. These antibodies are found in the sera of patients with paraneoplastic opsoclonus-ataxia, breast cancer, and small cell lung cancer. Alternatively spliced transcripts encoding distinct isoforms have been described.

    Alias Symbols: Nova-1

    Protein Interaction Partner: NOVA1,PCBP1,SMARCC2

    Protein Size: 507

    Poids moléculaire

    52 kDa

    ID gène

    4857

    NCBI Accession

    NM_002515, NP_002506

    UniProt

    A8K603
Vous êtes ici:
Chat with us!